These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 13637622)

  • 1. The effect of chlorpropamide on alloxan diabetes in mice.
    GRANDE F; MARTINEZ C
    Ann N Y Acad Sci; 1959 Mar; 74(3):817-9. PubMed ID: 13637622
    [No Abstract]   [Full Text] [Related]  

  • 2. Some effects of salicylate, chlorpropamide and insulin on carbohydrate metabolism in normal and diabetic rats.
    ANDREWS MM
    Metabolism; 1961 Sep; 10():678-83. PubMed ID: 13861498
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparison between sensitivity to chlorpropamide and to other oral hypoglycemic agents in diabetes mellitus].
    PALMAS S
    Minerva Med; 1959 Aug; 50():2570-3. PubMed ID: 14429972
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative evaluation of the hypoglycemic activity of the vegetal complex of Phaseolus vulgaris and chlorpropamide in experimental diabetes].
    Khaleeva LD; Maloshtan LN; Sytnik AG
    Probl Endokrinol (Mosk); 1987; 33(2):69-71. PubMed ID: 3601894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observations on the mode of action and clinical effects of chlorpropamide in diabetes mellitus.
    LEEVY CM; TORNOW A; GREENBERG P; ZINKE M
    Ann N Y Acad Sci; 1959 Mar; 74(3):725-37. PubMed ID: 13637614
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of chlorpropamide on endocrine function in patients with diabetes mellitus and its effects in other endocrine disorders.
    HAMWI GJ; SKILLMAN TG; KRUGER FA; FREEDY LR
    Ann N Y Acad Sci; 1959 Mar; 74(3):1003-11. PubMed ID: 13637645
    [No Abstract]   [Full Text] [Related]  

  • 7. The correlation between oral dosage, blood levels, and clinical and metabolic activity of chlorpropamide in the treatment of diabetes mellitus.
    BEASER SB
    Ann N Y Acad Sci; 1959 Mar; 74(3):701-8. PubMed ID: 13637611
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies with oral hypoglycemic agents. II. Contribution to the study of acute oral overloading with chlorpropamide in normal individuals and diabetics].
    PEREIRA VG; GELMAN A; MELO EH; DEVESA RF; de JORGE F; WAJCHENBERG BL; SHANAIDER J; HOXTER G; MATTAR E; CINTRA AB
    Rev Paul Med; 1960 Jun; 56():403-30. PubMed ID: 14431751
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of chlorpropamide upon post-pancreatectomy and spontaneous diabetes.
    PINES KL; LEIFER E; GOODMAN D
    Ann N Y Acad Sci; 1959 Mar; 74(3):997-1002. PubMed ID: 13637644
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical study of the effects of chlorpropamide on normal subjects and on diabetics.
    CARDONNET LJ; STAFFIERI JJ; EBERHARDT DR; TOMMASINO PO; BERLI RR; MURATORIO J
    Ann N Y Acad Sci; 1959 Mar; 74(3):771-87. PubMed ID: 13637618
    [No Abstract]   [Full Text] [Related]  

  • 11. [The behavior of the blood insulin after administration of chlorpropamide in diabetic subjects].
    RODARI T; MAGGI G; SPECCHIA G
    Folia Endocrinol Mens Incretologia Incretoterapia; 1961 Oct; 14():625-31. PubMed ID: 14493077
    [No Abstract]   [Full Text] [Related]  

  • 12. [Modification of the blood glucagon level by treatment with chlorpropamide in diabetic patients].
    MAGGI G; RODARI T; GAMBA G
    Rev Iber Endocrinol; 1962; 9():93-5. PubMed ID: 14468276
    [No Abstract]   [Full Text] [Related]  

  • 13. [Behavior of the blood glucagon in diabetic subjects under treatment with chlorpropamide].
    MAGGI G; RODARI T; GAMBA G
    Folia Endocrinol Mens Incretologia Incretoterapia; 1961 Oct; 14():641-9. PubMed ID: 14468275
    [No Abstract]   [Full Text] [Related]  

  • 14. [New observations concerning the effects of the administration of chlorpropamide for 20 months on a dog sensitized to diabetes by subtotal depancreatation].
    LOUBATIERES A; MARIANI MM; SASSINE A; FRUTEAU DE LACLOS C
    C R Seances Soc Biol Fil; 1961; 155():335-8. PubMed ID: 13763658
    [No Abstract]   [Full Text] [Related]  

  • 15. [Variations in the blood cholesterol level in the diabetic during treatment with chlorpropamide].
    BERETTA P; PUNTURIERI E
    Minerva Med; 1959 Aug; 50():2562-3. PubMed ID: 13799184
    [No Abstract]   [Full Text] [Related]  

  • 16. Potentiating the diabetogenic effect of alloxan by N-sulphonyl-N-butylurea (BZ-55).
    MOSINGER B; BRAUN T
    Experientia; 1959 Aug; 15():317-8. PubMed ID: 14424566
    [No Abstract]   [Full Text] [Related]  

  • 17. Chlorpropamide in single dosage and the responses to insulin or glucose in diabetics: the absence of evidence of increased glucose utilization.
    DANOWSKI TS; LEINBERGER M; MATEER FM
    Ann N Y Acad Sci; 1959 Mar; 74(3):979-87. PubMed ID: 13637642
    [No Abstract]   [Full Text] [Related]  

  • 18. [ANTIDIABETIC ACTION OF HYPOGLYCEMIC SULFONAMIDE (CHLORPROPAMIDE) ON EXPERIMENTAL LATENT DIABETES IN DOGS].
    LOUBATIERES A; MARIANI MM; ALRIC R; FRUTEAUDELACLOS C
    C R Seances Soc Biol Fil; 1963; 157():2247-9. PubMed ID: 14137448
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experimental study of the "antabuse effect" of chlorpropamide].
    ROYER R; LAMARCHE M; DEBRY G
    C R Seances Soc Biol Fil; 1962; 156():305-7. PubMed ID: 14494753
    [No Abstract]   [Full Text] [Related]  

  • 20. [Action of chlorpropamide on the experimental prediabetic period in the rat].
    YABO R; D'ANNA L; FOGLIA VG
    Rev Soc Argent Biol; 1961; 37():163-9. PubMed ID: 14008667
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.